FERRERO, Ivana
FERRERO, Ivana
SCIENZE DELLA SANITA' PUBBLICA E PEDIATRICHE
The activity of STI571 in human osteosarcoma cells.
2005-01-01 Pessolano R;Mareschi K; Palmero A; Ferrero I; Grignani G.E; Madon E; Fagioli F.
Adult Stem cells and neurodegenerative diseases
2011-01-01 Mazzini L; Vercelli A; Ferrero I; ; Mareschi K; Nasuello N; Monaco F;Fagioli F
Amyotrophic lateral sclerosis:What goals for cell therapy?
2007-01-01 Mazzini L; Fagioli F; Testa L; Ferrero I; Mareschi K.
Analysis of Mesenchymal Stromal Cell Engraftment After Allogeneic HSCT in Pediatric Patients: A Large Multicenter Study
2018-01-01 Castello, Laura M; Leone, Marco; Adamini, Aloe; Castiglia, Sara; Mareschi, Katia; Ferrero, Ivana; Marco, De Gobbi; Carnevale-Schianca, Fabrizio; Fagioli, Franca; Berger, Massimo
Association between elevated prolactin levels and circulating erythroid precursors in dialyzed patients
2000-01-01 Bellone G; Rollino C; Borsa S; Ferrero I; Martina G; Carbone A; Mareschi K; Quarello F; Piccoli G; Emanuelli G; Matera L.
Autologous mesenchymal stem cells: clinical applications in amyotrophic lateral sclerosis.
2006-01-01 Mazzini L; Mareschi K; Ferrero I; Vassallo E; Oliveri G; Boccaletti R; Testa L; Livigni S; Fagioli F.
Bone marrow mesenchymal stem cells from healthy donors and sporadic amyotrophic lateral sclerosis patients.
2008-01-01 Ferrero I; Mazzini L; Rustichelli D; Gunetti M; Mareschi K; Testa L; Nasuelli N; Oggioni GD; Fagioli F.
COMPARING THE IMMUNOREGULATORY EFFECTS OF MESENCHYMAL STEM CELLS ISOALTED FROM BONE MARROW, PLACENTA AND AMNIOTIC FLUID
2014-01-01 Katia, Mareschi; Sara, Castiglia; Fiorella, Sanavio; Michela, Muraro; Paola, Montanari; Ilaria, Galliano; Massimiliano, Bergallo; Ivana, Ferrero; Franca, Fagioli
Cytokine-induced killer cells eradicate bone and soft-tissue sarcomas.
2014-01-01 Sangiolo D; Mesiano G; Gammaitoni L; Leuci V; Todorovic M; Giraudo L; Cammarata C; Dell'aglio C; D'Ambrosio L; Pisacane A; Sarotto I; Miano S; Ferrero I; Carnevale-Schianca F; Pignochino Y; Sassi F; Bertotti A; Piacibello W; Fagioli F; Aglietta M; Grignani G.
Cytokines induced killer cells produced in good manufacturing practices conditions: identification of the most advantageous and safest expansion method in terms of viability, cellular growth and identity
2018-01-01 Castiglia, Sara; Adamini, Aloe; Rustichelli, Deborah; Castello, Laura; Mareschi, Katia; Pinnetta, Giuseppe; Leone, Marco; Mandese, Alessandra; Ferrero, Ivana; Mesiano, Giulia; Fagioli, Franca
Differential expression of transforming growth factors-beta1, -beta2 and -beta3in human colon carcinoma.
2001-01-01 Bellone G; Carbone A; Tibaudi D; Mauri F; Ferrero I; Smirne C; Suman F; Rivetti C; Migliaretti G; Camandona M; Palestro G; Emanuelli G; Rodeck U.
Dissection of the biphasic nature of hypoxia-induced motogenic action in bone marrow-derived human mesenchymal stem cells.
2011-01-01 Busletta C; Novo E; Valfrè Di Bonzo L; Povero D; Paternostro C; Ievolella M; Mareschi K; Ferrero I; Cannito S; Compagnone A; Bandino A; Colombatto S; Fagioli F; Parola M.
Effect of in vitro exposure of corticosteroid drugs, conventionally used in AMD treatment, on mesenchymal stem cells
2012-01-01 Nuzzi R; Gunetti M; Rustichelli D; Roagna B; Fronticelli Bardelli F; Fagioli F; Ferrero I.
Engraftment of bone marrow – derived human mesenchymal stem cells in normal and injured liver of NOD/SCID mice
2006-01-01 Valfrè di Bonzo L.; Ferrero I.; Novo E.; Rustichelli D.; Mareschi K.; Sanavio F.; Cannito S.; Zamara E.; Davit A.; Francica S.; Novelli F.; Colombatto S.; Fagioli F.; Parola M.
Ex vivo expanded mesenchymal stromal cell minimal quality requirements for clinical application
2015-01-01 Torre ML; Lucarelli E; Guidi S; Ferrari M; Alessandri G; De Girolamo L; Pessina A; Ferrero I; Gruppo Italiano Staminali Mesenchimali (GISM); Biagi E; Del Bue M; Frigerio S; Lisini D; Marazzi M; Mareschi K; Nava S; Parolini O; Riccobon A; Romagnoli L; Vigano M.
Ex vivo-expanded bone marrow CD34(+) for acute myocardial infarction treatment: in vitro and in vivo studies.
2011-01-01 Gunetti M; Noghero A; Molla F; Staszewsky LI; de Angelis N; Soldo A; Russo I; Errichiello E; Frasson C; Rustichelli D; Ferrero I; Gualandris A; Berger M; Geuna M; Scacciatella P; Basso G; Marra S; Bussolino F; Latini R; Fagioli F.
Expansion of mesenchymal stem cells isolated from paediatric and adult donor bone marrow
2006-01-01 Mareschi K.; Ferrero I; Rustichelli D.; Aschero S.; Gammaitoni L.; Aglietta M.; Madon E.; Fagioli F.
GMP compliant isolation and expansion of MSCs with inactivated human platelet lysate
2015-01-01 K. Mareschi , S. Castiglia, L Labanca, G. Lucania, M. Leone, D. Rustichelli, M. Muraro, M.Bergallo, A. Adamini, A. M. Bordiga, I. Ferrero, F. Fagioli
High energy shock waves enhance the cytotoxic effect of doxorubicin and methotrexate to human osteosarcoma cell lines
2006-01-01 PALMERO A ;BERGER M ;VENTURI C ;FERRERO I ;RUSTICHELLI D ;BERTA L ;FRAIRIA R ;MADON E ;FAGIOLI F
High-dose thiotepa and etoposide in children with poor-prognosis brain tumors
2004-01-01 FAGIOLI F; BIASIN E; MASTRODICASA L; SANDRI A; FERRERO I; BERGER M; VASSALLO E; MADON E
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| The activity of STI571 in human osteosarcoma cells. | 2005 | Pessolano R;Mareschi K; Palmero A; Ferrero I; Grignani G.E; Madon E; Fagioli F. | |
| Adult Stem cells and neurodegenerative diseases | 2011 | Mazzini L; Vercelli A; Ferrero I; ; Mareschi K; Nasuello N; Monaco F;Fagioli F | |
| Amyotrophic lateral sclerosis:What goals for cell therapy? | 2007 | Mazzini L; Fagioli F; Testa L; Ferrero I; Mareschi K. | |
| Analysis of Mesenchymal Stromal Cell Engraftment After Allogeneic HSCT in Pediatric Patients: A Large Multicenter Study | 2018 | Castello, Laura M; Leone, Marco; Adamini, Aloe; Castiglia, Sara; Mareschi, Katia; Ferrero, Ivana; Marco, De Gobbi; Carnevale-Schianca, Fabrizio; Fagioli, Franca; Berger, Massimo | |
| Association between elevated prolactin levels and circulating erythroid precursors in dialyzed patients | 2000 | Bellone G; Rollino C; Borsa S; Ferrero I; Martina G; Carbone A; Mareschi K; Quarello F; Piccoli G; Emanuelli G; Matera L. | |
| Autologous mesenchymal stem cells: clinical applications in amyotrophic lateral sclerosis. | 2006 | Mazzini L; Mareschi K; Ferrero I; Vassallo E; Oliveri G; Boccaletti R; Testa L; Livigni S; Fagioli F. | |
| Bone marrow mesenchymal stem cells from healthy donors and sporadic amyotrophic lateral sclerosis patients. | 2008 | Ferrero I; Mazzini L; Rustichelli D; Gunetti M; Mareschi K; Testa L; Nasuelli N; Oggioni GD; Fagioli F. | |
| COMPARING THE IMMUNOREGULATORY EFFECTS OF MESENCHYMAL STEM CELLS ISOALTED FROM BONE MARROW, PLACENTA AND AMNIOTIC FLUID | 2014 | Katia, Mareschi; Sara, Castiglia; Fiorella, Sanavio; Michela, Muraro; Paola, Montanari; Ilaria, Galliano; Massimiliano, Bergallo; Ivana, Ferrero; Franca, Fagioli | |
| Cytokine-induced killer cells eradicate bone and soft-tissue sarcomas. | 2014 | Sangiolo D; Mesiano G; Gammaitoni L; Leuci V; Todorovic M; Giraudo L; Cammarata C; Dell'aglio C; D'Ambrosio L; Pisacane A; Sarotto I; Miano S; Ferrero I; Carnevale-Schianca F; Pignochino Y; Sassi F; Bertotti A; Piacibello W; Fagioli F; Aglietta M; Grignani G. | |
| Cytokines induced killer cells produced in good manufacturing practices conditions: identification of the most advantageous and safest expansion method in terms of viability, cellular growth and identity | 2018 | Castiglia, Sara; Adamini, Aloe; Rustichelli, Deborah; Castello, Laura; Mareschi, Katia; Pinnetta, Giuseppe; Leone, Marco; Mandese, Alessandra; Ferrero, Ivana; Mesiano, Giulia; Fagioli, Franca | |
| Differential expression of transforming growth factors-beta1, -beta2 and -beta3in human colon carcinoma. | 2001 | Bellone G; Carbone A; Tibaudi D; Mauri F; Ferrero I; Smirne C; Suman F; Rivetti C; Migliaretti G; Camandona M; Palestro G; Emanuelli G; Rodeck U. | |
| Dissection of the biphasic nature of hypoxia-induced motogenic action in bone marrow-derived human mesenchymal stem cells. | 2011 | Busletta C; Novo E; Valfrè Di Bonzo L; Povero D; Paternostro C; Ievolella M; Mareschi K; Ferrero I; Cannito S; Compagnone A; Bandino A; Colombatto S; Fagioli F; Parola M. | |
| Effect of in vitro exposure of corticosteroid drugs, conventionally used in AMD treatment, on mesenchymal stem cells | 2012 | Nuzzi R; Gunetti M; Rustichelli D; Roagna B; Fronticelli Bardelli F; Fagioli F; Ferrero I. | |
| Engraftment of bone marrow – derived human mesenchymal stem cells in normal and injured liver of NOD/SCID mice | 2006 | Valfrè di Bonzo L.; Ferrero I.; Novo E.; Rustichelli D.; Mareschi K.; Sanavio F.; Cannito S.; Zamara E.; Davit A.; Francica S.; Novelli F.; Colombatto S.; Fagioli F.; Parola M. | |
| Ex vivo expanded mesenchymal stromal cell minimal quality requirements for clinical application | 2015 | Torre ML; Lucarelli E; Guidi S; Ferrari M; Alessandri G; De Girolamo L; Pessina A; Ferrero I; Gruppo Italiano Staminali Mesenchimali (GISM); Biagi E; Del Bue M; Frigerio S; Lisini D; Marazzi M; Mareschi K; Nava S; Parolini O; Riccobon A; Romagnoli L; Vigano M. | |
| Ex vivo-expanded bone marrow CD34(+) for acute myocardial infarction treatment: in vitro and in vivo studies. | 2011 | Gunetti M; Noghero A; Molla F; Staszewsky LI; de Angelis N; Soldo A; Russo I; Errichiello E; Frasson C; Rustichelli D; Ferrero I; Gualandris A; Berger M; Geuna M; Scacciatella P; Basso G; Marra S; Bussolino F; Latini R; Fagioli F. | |
| Expansion of mesenchymal stem cells isolated from paediatric and adult donor bone marrow | 2006 | Mareschi K.; Ferrero I; Rustichelli D.; Aschero S.; Gammaitoni L.; Aglietta M.; Madon E.; Fagioli F. | |
| GMP compliant isolation and expansion of MSCs with inactivated human platelet lysate | 2015 | K. Mareschi , S. Castiglia, L Labanca, G. Lucania, M. Leone, D. Rustichelli, M. Muraro, M.Bergallo, A. Adamini, A. M. Bordiga, I. Ferrero, F. Fagioli | |
| High energy shock waves enhance the cytotoxic effect of doxorubicin and methotrexate to human osteosarcoma cell lines | 2006 | PALMERO A ;BERGER M ;VENTURI C ;FERRERO I ;RUSTICHELLI D ;BERTA L ;FRAIRIA R ;MADON E ;FAGIOLI F | |
| High-dose thiotepa and etoposide in children with poor-prognosis brain tumors | 2004 | FAGIOLI F; BIASIN E; MASTRODICASA L; SANDRI A; FERRERO I; BERGER M; VASSALLO E; MADON E |